BusinessHemispherx Biopharma Enters into Alfa-n3 Interferon Clinical Trial, Sales, Marketing, Distribution, and Supply Agreement with Saudi Arabia’s Premier Pharma Company in Fight Against the Deadly MERS DiseaseBy Nasdaq OMXApr 4, 2016, 12:30 PM UTC
